| 1 min read
Register for free to listen to this article
Listen with Speechify
0:00
1:00
WASHINGTON, D.C.—In an attempt to address what they callAmerica's "destructive spending pattern," members of the U.S. HouseAppropriations Committee have proposed a $285 million cut to the U.S. Food andDrug Administration's (FDA) 2012 spending bill.
 
 
"As is the goal of all our appropriations bills thisyear, this legislation reflects hard decisions to cut lower priority programs,reduce spending in programs that can be scaled back, and target funds wherethey are needed most so that our nation continues on the path to fiscalrecovery," said Rep. Harold Rogers, R-Ky., and chairman of the committee.
 
 
The proposed budget, which the committee voted on by voicein late May, would bring the FDA's total budget for next year to $3.7 billion.The bill would also set the FDA's appropriations level at $2.2 billion, about$300 million below current levels and almost $600 million below PresidentBarack Obama's request.
 
 
In addition to the funding it collects from Congress, theFDA also receives funding from the pharmaceutical and medical deviceindustries, which pay the agency to review new product applications.
 
Some industry and consumer groups have been pushing for anincrease in FDA spending since the end of the Bush administration, in aresponse to high-profile drug contamination cases.
 
The bill was expected to pass as this issue went to press.

About the Author

Related Topics

Published In

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

GreenCooling

Thermo Scientific™ Centrifuges with GreenCool Technology

Next-generation natural refrigerant cooling system for centrifuges, offering a lower Global Warming Potential and reduced energy consumption.
Clear sample tubes are shown in a clear tote with red lids in a sample prep robot with a blue and silver industrial lab background.

The crucial role of sample preparation in biotherapy manufacturing

Discover how better sample preparation can unlock improved assay accuracy and analytical results.
A black mosquito is shown on pink human skin against a blurred green backdrop.

Discovering deeper insights into malaria research

Malaria continues to drive urgent research worldwide, with new therapies and tools emerging to combat the parasite’s complex lifecycle and global burden.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue